Rankings
▼
Calendar
BCYC Q4 2018 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena
BCYC
Bicycle Therapeutics plc
$360M
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
+61.4% YoY
Gross Profit
-$5M
-514.3% margin
Operating Income
-$8M
-713.5% margin
Net Income
-$7M
-628.3% margin
EPS (Diluted)
$-0.50
QoQ Revenue Growth
-34.3%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$207,000
Balance Sheet
Total Assets
$82M
Total Liabilities
$151M
Stockholders' Equity
-$70M
Cash & Equivalents
$63M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$655,000
+61.4%
Gross Profit
-$5M
-$3M
-57.6%
Operating Income
-$8M
-$6M
-25.3%
Net Income
-$7M
-$6M
-14.0%
← FY 2018
All Quarters
Q1 2019 →